BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11665749)

  • 1. Is tumor expression of the major histocompatibility complex antigen required for T cell immune surveillance?
    Liu Y; Zheng P
    Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 2():S61-4. PubMed ID: 11665749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T helper cell response is required for memory in CD8+ T lymphocytes induced by a poly(I:C)-adjuvanted MHC I-restricted peptide epitope.
    Qiu F; Cui Z
    J Immunother; 2007; 30(2):180-9. PubMed ID: 17471165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class I antigens, immune surveillance, and tumor immune escape.
    Garcia-Lora A; Algarra I; Garrido F
    J Cell Physiol; 2003 Jun; 195(3):346-55. PubMed ID: 12704644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of major histocompatibility complex class I, class II and TLA genes on tumor rejection.
    Ostrand-Rosenberg S; Garcia EP; Roby CA; Clements VK
    Semin Cancer Biol; 1991 Oct; 2(5):311-9. PubMed ID: 1773047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class I and class II major histocompatibility complex antigens expression on human hepatocytes and hepatoma cells: an approach with high sensitivity and specificity.
    Chiu JH; Lui WY; Chang HM; Loong CC; Wu LH; Kao HL; Wu CW
    Cytometry; 1997 Dec; 30(6):317-23. PubMed ID: 9440824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class I antigens and immune surveillance in transformed cells.
    Aptsiauri N; Cabrera T; Garcia-Lora A; Lopez-Nevot MA; Ruiz-Cabello F; Garrido F
    Int Rev Cytol; 2007; 256():139-89. PubMed ID: 17241907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I.
    von Geldern M; Simm B; Braun M; Weiss EH; Schendel DJ; Falk CS
    Eur J Immunol; 2006 Sep; 36(9):2347-58. PubMed ID: 16909431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The number of long-lasting functional memory CD8+ T cells generated depends on the nature of the initial nonspecific stimulation.
    Fernando GJ; Khammanivong V; Leggatt GR; Liu WJ; Frazer IH
    Eur J Immunol; 2002 Jun; 32(6):1541-9. PubMed ID: 12115636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
    Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC class I down-regulation: tumour escape from immune surveillance? (review).
    Bubeník J
    Int J Oncol; 2004 Aug; 25(2):487-91. PubMed ID: 15254748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.
    Holling TM; Schooten E; van Den Elsen PJ
    Hum Immunol; 2004 Apr; 65(4):282-90. PubMed ID: 15120183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor escape from immune surveillance.
    Costello RT; Gastaut JA; Olive D
    Arch Immunol Ther Exp (Warsz); 1999; 47(2):83-8. PubMed ID: 10202560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting MHC class I expression and class I/class II reciprocity in the CNS: reconciling divergent findings.
    Lampson LA
    Microsc Res Tech; 1995 Nov; 32(4):267-85. PubMed ID: 8573777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I-restricted cytotoxic T cells and the rejection of a cognate antigen-expressing model tumor.
    Eriksson K; Sun JB; Nordström I; Fredriksson M; Lindblad M; Li BL; Holmgren J
    Eur J Immunol; 2004 May; 34(5):1272-81. PubMed ID: 15114660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidation.
    Hillman GG; Kallinteris NL; Lu X; Wang Y; Wright JL; Li Y; Wu S; Forman JD; Gulfo JV; Humphreys RE; Xu M
    Cancer Treat Rev; 2004 May; 30(3):281-90. PubMed ID: 15059651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
    Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
    Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.